Rofecoxib does not inhibit aberrant crypt foci formation but inhibits later steps in the development of experimental colorectal cancer: Rofecoxib in experimental colon cancer

Author： Perše Martina   Zebic Ana   Cerar Anton  

Publisher： Informa Healthcare

ISSN： 0036-5521

Source： Scandinavian Journal of Gastroenterology, Vol.40, Iss.1, 2005-01, pp. : 61-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of COX-2 Inhibition by Rofecoxib on Serum and Tumor Progastrin and Gastrin Levels and Expression of PPARγ and Apoptosis-Related Proteins in Gastric Cancer Patients

By Konturek Peter C.   Konturek Stanislaw J.   Bielanski Wladyslaw   Kania J.   Żuchowicz Monika   Hartwich Artur   Rehfeld Jens F.   Hahn Eckhart G.  

Digestive Diseases and Sciences, Vol. 48, Iss. 10, 2003-10 ,pp. : 2005-2017

Springer Publishing Company

Access to resources Recommend Favorite

Polyethylene glycol, unique among laxatives, suppresses aberrant crypt foci, by elimination of cells

By Taché Sylviane   Parnaud Géraldine   Van Beek Erik   Corpet Denis  

Scandinavian Journal of Gastroenterology, Vol. 41, Iss. 6, 2006-06 ,pp. : 730-736

Informa Healthcare

Access to resources Recommend Favorite

Effect of Concomitant Polyethylene Glycol and Celecoxib on Colonic Aberrant Crypt Foci and Tumors in F344 Rats

By Do Khoa   Barnard Graham  

Digestive Diseases and Sciences, Vol. 50, Iss. 7, 2005-07 ,pp. : 1304-1311

Springer Publishing Company

Access to resources Recommend Favorite

Celecoxib and Curcumin Additively Inhibit the Growth of Colorectal Cancer in a Rat Model

By  

Digestion, Vol. 74, Iss. 3-4, 2007-04 ,pp. : 140-144

Karger

Access to resources Recommend Favorite

Anthocyanins Prevent Colorectal Cancer Development in a Mouse Model

By  

Digestion, Vol. 95, Iss. 4, 2017-05 ,pp. : 275-280

Karger

Access to resources Recommend Favorite